Results 261 to 270 of about 302,479 (284)

LDL-C-Senkung 2.0

Info Diabetologie, 2016
Alirocumab von Sanofi senkt den LDL-Cholesterin (LDL-C)-Spiegel bei schwerer Hypercholesterinamie sehr effektiv. Von dem PCSK9-Hemmer konnen Patienten mit hohem kardiovaskularem Risiko und hohem LDL-C-Spiegel trotz maximaler lipidsenkender Standardtherapie profitieren.
openaire   +1 more source

LDL-C Estimation

Journal of the American College of Cardiology, 2022
Kevin C. Maki, Jelani K. Grant, Carl E. Orringer   +2 more
openaire   +1 more source

Effectiveness of rosuvastatin in reducing LDL-C and target LDL-C goal attainment in real-world clinical practice

Current Medical Research and Opinion, 2009
This article reviewed the collective evidence from routine clinical practice to summarize the existing literature on the effectiveness of rosuvastatin in treating hypercholesterolemia.A comprehensive Medline literature search identified all published articles, in all languages, from January 2003 through September 2008 on the use of rosuvastatin in the ...
Sanjay K, Gandhi, Krister, Järbrink, Kathleen M, Fox, Gunnar, Brandrup-Wognsen   +3 more
openaire   +2 more sources

Duale LDL-C-Senkung in Fixkombination

Info Diabetologie, 2015
Viele Typ-2-Diabetiker haben eine Fettleber mit dem Vollbild des metabolischen Syndroms. Um ihr besonders hohes kardiovaskulares Risiko zu reduzieren, ist die starke LDL-Cholesterinsenkung (LDL-C) wesentlich. Mit neuen Fixkombinationen von Statinen mit Ezetimib stehen hierfur sehr effektive Optionen zur Verfugung.
openaire   +1 more source

LDL-C-Lowering therapy: Current and future therapeutic targets

Current Cardiology Reports, 2008
Recent trials have emphasized that more intensive low-density lipoprotein cholesterol (LDL-C) lowering results in a further reduction in cardiovascular disease risk. Uptitration of statins has limited incremental LDL-C-lowering effects and leads to an increased incidence of side effects.
Visser, Maartje E., Jakulj, Lily, Kastelein, John J. P., Stroes, Erik S. G.   +3 more
openaire   +3 more sources

Lipoprotein(a) and LDL-C

Journal of the American College of Cardiology, 2022
Pamela B. Morris, Jagat Narula, Sotirios Tsimikas   +2 more
openaire   +1 more source

Assessment of LDL-C Calculation Using the Newly Adopted NIH LDL-C Equation in a Pediatric Population

Clinical Chemistry, 2022
Ka Keung, Chan, Jane A, Dickerson
openaire   +2 more sources

Reduction of Serum LDL-C Levels

American Journal of Cardiovascular Drugs, 2003
The association between elevated serum cholesterol levels and cardiovascular risk was established several decades ago by studies such as the Framingham study and the Multiple Risk Factor Intervention Trial (MRFIT). Both primary and secondary prevention trials of cholesterol lowering, using HMG-CoA reductase inhibitors, have demonstrated clear benefits ...
openaire   +2 more sources

LDL-C-Senkung um 85%

MMW - Fortschritte der Medizin, 2021
openaire   +1 more source

Effektive LDL-C-Senkung

CME, 2021
openaire   +1 more source